GSK begins U.S. test of experimental drug for pneumonia from COVID-19
June 09, 2020 at 12:05 PM EDT
GlaxoSmithKline (GSK) has started a trial in the United States to test an experimental rheumatoid arthritis drug on patients suffering from pneumonia caused by COVID-19, the British drugmaker said on Tuesday.
